121 results
425
EX-99.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
in the Registration Statement, the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available. Shareholders
425
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
transaction, will be set forth in the Registration Statement, the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when
425
EX-2.1
jnoc8i
26 May 23
Business combination disclosure
5:14pm
8-K
3ea 785s00e
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-2.1
xn9huk4tqxf0k3c3h3bu
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-99.1
us7px
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
D
z1nns4mfv7fn
14 Dec 22
$3.40 mm in debt / options, 12 investors
4:54pm
8-K
EX-10.1
0p680n mco9o
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
hfbs4bxo
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
cn2 ljh563vk3
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.2
5x7j72
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
DEF 14C
413hk8427khvozwv
2 Jun 22
Information statement
9:15am